TrialJournal of hematology & oncology2017

Platelet desialylation is a novel mechanism and a therapeutic target in thrombocytopenia during sepsis: an open-label, multicenter, randomized controlled trial.

Mei-Feng Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.